Jenburkt Pharma - Quaterly Results

07 Nov 2023 Evaluate
A fair growth of 6.80% in the revenue at Rs. 382.89 millions was reported in the September 2023 quarter as compared to Rs. 358.52 millions during year-ago period.Modest increase of 6.64% in the Net Profit was reported from. 68.66 millions to Rs. 73.22  millions.Operating profit for the quarter ended September 2023 rose to 102.00 millions as compared to 98.78 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 382.89 358.52 6.80 674.64 669.84 0.72 1367.49 1239.80 10.30
Other Income 10.96 12.61 -13.08 21.33 24.04 -11.27 51.23 49.49 3.52
PBIDT 102.00 98.78 3.26 182.05 182.93 -0.48 354.90 322.04 10.20
Interest 0.69 0.94 -26.60 1.43 1.81 -20.99 3.67 4.35 -15.63
PBDT 101.31 97.84 3.55 180.62 181.12 -0.28 351.23 317.69 10.56
Depreciation 5.91 5.45 8.44 10.91 10.80 1.02 22.59 18.99 18.96
PBT 95.40 92.39 3.26 169.71 170.32 -0.36 328.64 298.70 10.02
TAX 22.18 23.73 -6.53 42.79 42.13 1.57 82.58 75.74 9.03
Deferred Tax -3.48 -1.27 174.02 -2.89 -2.10 37.62 -2.25 2.96 -176.01
PAT 73.22 68.66 6.64 126.92 128.19 -0.99 246.06 222.96 10.36
Equity 44.13 45.89 -3.84 44.13 45.89 -3.84 44.13 45.89 -3.84
PBIDTM(%) 26.64 27.55 -3.31 26.98 27.31 -1.19 25.95 25.98 -0.09

Jenburkt Pharma Share Price

1100.85 11.05 (1.01%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×